- Home
- TRIB vs CDIO Comparison
TRIB vs CDIO Comparison
Compare TRIB & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- CDIO
- Stock Information
- Founded
- TRIB 1992
- CDIO 2017
- Country
- TRIB Ireland
- CDIO United States
- Employees
- TRIB N/A
- CDIO N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- TRIB Health Care
- CDIO Health Care
- Exchange
- TRIB Nasdaq
- CDIO Nasdaq
- Market Cap
- TRIB 5.4M
- CDIO 6.4M
- IPO Year
- TRIB N/A
- CDIO N/A
- Fundamental
- Price
- TRIB $1.09
- CDIO N/A
- Analyst Decision
- TRIB
- CDIO
- Analyst Count
- TRIB 0
- CDIO 0
- Target Price
- TRIB N/A
- CDIO N/A
- AVG Volume (30 Days)
- TRIB 101.5K
- CDIO 40.0K
- Earning Date
- TRIB 11-14-2025
- CDIO 11-12-2025
- Dividend Yield
- TRIB N/A
- CDIO N/A
- EPS Growth
- TRIB N/A
- CDIO N/A
- EPS
- TRIB N/A
- CDIO N/A
- Revenue
- TRIB $61,555,000.00
- CDIO $19,507.00
- Revenue This Year
- TRIB $13.51
- CDIO $1,434.82
- Revenue Next Year
- TRIB $13.14
- CDIO $4,661.91
- P/E Ratio
- TRIB N/A
- CDIO N/A
- Revenue Growth
- TRIB 8.31
- CDIO N/A
- 52 Week Low
- TRIB $0.48
- CDIO $3.22
- 52 Week High
- TRIB $3.44
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- TRIB 44.39
- CDIO 58.63
- Support Level
- TRIB $1.00
- CDIO $4.16
- Resistance Level
- TRIB $1.17
- CDIO $4.63
- Average True Range (ATR)
- TRIB 0.07
- CDIO 0.33
- MACD
- TRIB -0.00
- CDIO 0.03
- Stochastic Oscillator
- TRIB 30.48
- CDIO 56.28
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.